Lactoferrin Protects Against Rotenone-Induced Toxicity in Dopaminergic SH-SY5Y Cells through the Modulation of Apoptotic-Associated Pathways.
Lactoferrin
Neuroprotection
Parkinson’s disease
Rotenone
SH-SY5Y
Journal
Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991
Informations de publication
Date de publication:
19 Sep 2024
19 Sep 2024
Historique:
received:
16
06
2024
accepted:
12
09
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
19
9
2024
Statut:
epublish
Résumé
Parkinson's disease (PD) is a common motor neurodegenerative disease that still lacks effective therapeutic options. Previous studies have reported that lactoferrin exhibited neuroprotective effects in cellular and animal models of PD, typically induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium (MPP
Identifiants
pubmed: 39297981
doi: 10.1007/s12031-024-02267-7
pii: 10.1007/s12031-024-02267-7
doi:
Substances chimiques
Rotenone
03L9OT429T
Lactoferrin
EC 3.4.21.-
Neuroprotective Agents
0
Reactive Oxygen Species
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88Subventions
Organisme : Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS)
ID : FRGS/1/2020/SKK0/SYUC/02/1
Organisme : Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS)
ID : FRGS/1/2020/SKK0/SYUC/02/1
Organisme : Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS)
ID : FRGS/1/2020/SKK0/SYUC/02/1
Organisme : Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS)
ID : FRGS/1/2020/SKK0/SYUC/02/1
Organisme : Sunway University Internal Grant
ID : GRTIN-IRG-23-2021
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Ahmadi FA, Grammatopoulos TN, Poczobutt AM, Jones SM, Snell LD, Das M, Zawada WM (2008) Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis. Neurochem Res 33(5):886–901. https://doi.org/10.1007/s11064-007-9532-5
doi: 10.1007/s11064-007-9532-5
pubmed: 17992568
Adomshick V, Pu Y, Veiga-Lopez A (2020) Automated lipid droplet quantification system for phenotypic analysis of adipocytes using Cell Profiler. Toxicol Mech Methods 30(5):378–387. https://doi.org/10.1080/15376516.2020.1747124
doi: 10.1080/15376516.2020.1747124
pubmed: 32208812
pmcid: 7533149
Ali N, Sane MS, Tang H, Compher J, McLaughlin Q, Jones CD, Maffi SK (2023) 6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons. Neurochem Int 170:105608. https://doi.org/10.1016/j.neuint.2023.105608
doi: 10.1016/j.neuint.2023.105608
pubmed: 37678429
Ali H, Jabeen A, Maharjan R, Nadeem-Ul-Haque M, Aamra H, Nazir S, Khan S, Olleik H, Maresca M, & Shaheen F (2020). Furan-Conjugated Tripeptides as Potent Antitumor Drugs. Biomolecules, 10(12). https://doi.org/10.3390/biom10121684
Bhurtel S, Katila N, Srivastav S, Neupane S, Choi DY (2019) Mechanistic comparison between MPTP and rotenone neurotoxicity in mice. Neurotoxicology 71:113–121. https://doi.org/10.1016/j.neuro.2018.12.009
doi: 10.1016/j.neuro.2018.12.009
pubmed: 30605763
Binolfi A, Limatola A, Verzini S, Kosten J, Theillet FX, Rose HM, Bekei B, Stuiver M, van Rossum M, Selenko P (2016) Intracellular repair of oxidation-damaged alpha-synuclein fails to target C-terminal modification sites. Nat Commun 7:10251. https://doi.org/10.1038/ncomms10251
doi: 10.1038/ncomms10251
pubmed: 26807843
pmcid: 4737712
Bisbal M, Sanchez M (2019) Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach. Neural Regen Res 14(5):762–766. https://doi.org/10.4103/1673-5374.249847
doi: 10.4103/1673-5374.249847
pubmed: 30688258
pmcid: 6375050
Borland MK, Trimmer PA, Rubinstein JD, Keeney PM, Mohanakumar K, Liu L, Bennett JP Jr (2008) Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson’s disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol Neurodegener 3:21. https://doi.org/10.1186/1750-1326-3-21
doi: 10.1186/1750-1326-3-21
pubmed: 19114014
pmcid: 2631511
Brakedal B, Toker L, Haugarvoll K, Tzoulis C (2022) A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population. NPJ Parkinsons Dis 8(1):19. https://doi.org/10.1038/s41531-022-00280-4
doi: 10.1038/s41531-022-00280-4
pubmed: 35236852
pmcid: 8891365
Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence. FEBS J 277(1):2–21. https://doi.org/10.1111/j.1742-4658.2009.07366.x
doi: 10.1111/j.1742-4658.2009.07366.x
pubmed: 19843174
Christensen ML, Braunstein TH, Treiman M (2008) Fluorescence assay for mitochondrial permeability transition in cardiomyocytes cultured in a microtiter plate. Anal Biochem 378(1):25–31. https://doi.org/10.1016/j.ab.2008.03.042
doi: 10.1016/j.ab.2008.03.042
pubmed: 18417075
Coogan AN, O’Leary DM, O’Connor JJ (1999) P42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. J Neurophysiol 81(1):103–110. https://doi.org/10.1152/jn.1999.81.1.103
doi: 10.1152/jn.1999.81.1.103
pubmed: 9914271
Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J (2000) Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 79(4):583–593 ( https://www.ncbi.nlm.nih.gov/pubmed/10996849 )
doi: 10.1002/1097-4644(20001215)79:4<583::AID-JCB70>3.0.CO;2-9
pubmed: 10996849
Dian LH, Hu YJ, Lin JY, Zhang JY, Yan Y, Cui YN, Su ZB, Lu WL (2018) Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. Int J Nanomedicine 13:719–731. https://doi.org/10.2147/IJN.S150140
doi: 10.2147/IJN.S150140
pubmed: 29440897
pmcid: 5799853
Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis 3(4):461–491. https://doi.org/10.3233/JPD-130230
doi: 10.3233/JPD-130230
pubmed: 24252804
pmcid: 4135313
Dorra EG, Aida E, Zaineb D, Imene BT, Fairouz S, Aicha S, Josse L, Leila CG (2021) Luteolin Induced Apoptosis and Blockage of P-Glycoprotein in Human Sarcoma Cell Lines. Cancer Ther Oncol Intl J 18(5):555997. https://doi.org/10.19080/CTOIJ.2021.18.555997
doi: 10.19080/CTOIJ.2021.18.555997
Edlich F (2018) BCL-2 proteins and apoptosis: Recent insights and unknowns. Biochem Biophys Res Commun 500(1):26–34. https://doi.org/10.1016/j.bbrc.2017.06.190
doi: 10.1016/j.bbrc.2017.06.190
pubmed: 28676391
Eker F, Bolat E, Pekdemir B, Duman H, Karav S (2023) Lactoferrin: neuroprotection against Parkinson’s disease and secondary molecule for potential treatment. Front Aging Neurosci 15:1204149. https://doi.org/10.3389/fnagi.2023.1204149
doi: 10.3389/fnagi.2023.1204149
pubmed: 37731953
pmcid: 10508234
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516. https://doi.org/10.1080/01926230701320337
doi: 10.1080/01926230701320337
pubmed: 17562483
pmcid: 2117903
Ferlazzo N, Curro M, Giunta ML, Longo D, Rizzo V, Caccamo D, Ientile R (2020) Up-regulation of HIF-1alpha is associated with neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells. Amino Acids 52(2):171–179. https://doi.org/10.1007/s00726-019-02759-6
doi: 10.1007/s00726-019-02759-6
pubmed: 31292720
Fillebeen C, Dehouck B, Benaissa M, Dhennin-Duthille I, Cecchelli R, Pierce A (1999a) Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J Neurochem 73(6):2491–2500. https://doi.org/10.1046/j.1471-4159.1999.0732491.x
doi: 10.1046/j.1471-4159.1999.0732491.x
pubmed: 10582610
Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli R, Pierce A (1999b) Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274(11):7011–7017. https://doi.org/10.1074/jbc.274.11.7011
doi: 10.1074/jbc.274.11.7011
pubmed: 10066755
Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G, Pierce A (1999c) Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res 72(2):183–194. https://doi.org/10.1016/s0169-328x(99)00221-1
doi: 10.1016/s0169-328x(99)00221-1
pubmed: 10529477
Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaissa M, Pierce A (2001) Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 96(1–2):103–113. https://doi.org/10.1016/s0169-328x(01)00216-9
doi: 10.1016/s0169-328x(01)00216-9
pubmed: 11731015
Galaris D, Barbouti A, Pantopoulos K (2019) Iron homeostasis and oxidative stress: An intimate relationship. Biochim Biophys Acta Mol Cell Res 1866(12):118535. https://doi.org/10.1016/j.bbamcr.2019.118535
doi: 10.1016/j.bbamcr.2019.118535
pubmed: 31446062
Giannakis A, Chondrogiorgi M, Tsironis C, Tatsioni A, Konitsiotis S (2018) Levodopa-induced dyskinesia in Parkinson’s disease: still no proof? A Meta-Analysis J Neural Transm (Vienna) 125(9):1341–1349. https://doi.org/10.1007/s00702-018-1841-0
doi: 10.1007/s00702-018-1841-0
pubmed: 29352351
Giordano S, Lee J, Darley-Usmar VM, Zhang J (2012) Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death. PLoS ONE 7(9):e44610. https://doi.org/10.1371/journal.pone.0044610
doi: 10.1371/journal.pone.0044610
pubmed: 22970265
pmcid: 3435291
Greenamyre JT, Betarbet R, Sherer TB (2003) The rotenone model of Parkinson’s disease: genes, environment and mitochondria. Parkinsonism Relat Disord 9:59–64. https://doi.org/10.1016/s1353-8020(03)00023-3
doi: 10.1016/s1353-8020(03)00023-3
Grey A, Zhu Q, Watson M, Callon K, Cornish J (2006) Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway. Mol Cell Endocrinol 251(1–2):96–102. https://doi.org/10.1016/j.mce.2006.03.002
doi: 10.1016/j.mce.2006.03.002
pubmed: 16650524
Guo C, Yang ZH, Zhang S, Chai R, Xue H, Zhang YH, Li JY, Wang ZY (2017) Intranasal Lactoferrin Enhances alpha-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1alpha Pathways in an Alzheimer’s Disease Mouse Model. Neuropsychopharmacology 42(13):2504–2515. https://doi.org/10.1038/npp.2017.8
doi: 10.1038/npp.2017.8
pubmed: 28079060
pmcid: 5686501
Guo B, Zheng C, Cao J, Qiu X, Luo F, Li H, Lee SM, Yang X, Zhang G, Sun Y, Zhang Z, Wang Y (2024) Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation. Neuromolecular Med 26(1):9. https://doi.org/10.1007/s12017-024-08775-4
doi: 10.1007/s12017-024-08775-4
pubmed: 38568291
Ho DH, Nam D, Seo MK, Park SW, Seol W, Son I (2021) LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells. Oxid Med Cell Longev 2021:9969842. https://doi.org/10.1155/2021/9969842
doi: 10.1155/2021/9969842
pubmed: 34306319
pmcid: 8282384
Hou Z, Imam MU, Ismail M, Azmi NH, Ismail N, Ideris A, Mahmud R (2015) Lactoferrin and ovotransferrin contribute toward antioxidative effects of Edible Bird’s Nest against hydrogen peroxide-induced oxidative stress in human SH-SY5Y cells. Biosci Biotechnol Biochem 79(10):1570–1578. https://doi.org/10.1080/09168451.2015.1050989
doi: 10.1080/09168451.2015.1050989
pubmed: 26057702
Ianiro G, Rosa L, Bonaccorsi di Patti MC, Valenti P, Musci G, Cutone A (2023) Lactoferrin: from the structure to the functional orchestration of iron homeostasis. Biometals 36(3):391–416. https://doi.org/10.1007/s10534-022-00453-x
doi: 10.1007/s10534-022-00453-x
pubmed: 36214975
Ioghen OC, Ceafalan LC, Popescu BO (2023) SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research-Old Practice for New Trends. J Integr Neurosci 22(1):20. https://doi.org/10.31083/j.jin2201020
doi: 10.31083/j.jin2201020
pubmed: 36722247
Ivashko-Pachima Y, Seroogy KB, Sharabi Y, Gozes I (2021) Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP. J Mol Neurosci 71(8):1515–1524. https://doi.org/10.1007/s12031-021-01876-w
doi: 10.1007/s12031-021-01876-w
pubmed: 34286456
Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson’s disease. Nat Protoc 2(1):141–151. https://doi.org/10.1038/nprot.2006.342
doi: 10.1038/nprot.2006.342
pubmed: 17401348
Jagmag SA, Tripathi N, Shukla SD, Maiti S, Khurana S (2015) Evaluation of Models of Parkinson’s Disease. Front Neurosci 9:503. https://doi.org/10.3389/fnins.2015.00503
doi: 10.3389/fnins.2015.00503
pubmed: 26834536
Javitch JA, D’Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82(7):2173–2177. https://doi.org/10.1073/pnas.82.7.2173
doi: 10.1073/pnas.82.7.2173
pubmed: 3872460
pmcid: 397515
Kamemori N, Takeuchi T, Sugiyama A, Miyabayashi M, Kitagawa H, Shimizu H, Ando K, Harada E (2008) Trans-endothelial and trans-epithelial transfer of lactoferrin into the brain through BBB and BCSFB in adult rats. J Vet Med Sci 70(3):313–315. https://doi.org/10.1292/jvms.70.313
doi: 10.1292/jvms.70.313
pubmed: 18388436
Kell DB, Heyden EL, Pretorius E (2020) The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front Immunol 11:1221. https://doi.org/10.3389/fimmu.2020.01221
doi: 10.3389/fimmu.2020.01221
pubmed: 32574271
pmcid: 7271924
Kim HJ, Song JY, Park HJ, Park HK, Yun DH, Chung JH (2009) Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells. Korean J Physiol Pharmacol 13(4):281–285. https://doi.org/10.4196/kjpp.2009.13.4.281
doi: 10.4196/kjpp.2009.13.4.281
pubmed: 19885011
pmcid: 2766708
Kopaeva Y, Cherepov AB, Zarayskaya IY, Nesterenko MV (2019) Transport of Human Lactoferrin into Mouse Brain: Administration Routes and Distribution. Bull Exp Biol Med 167(4):561–567. https://doi.org/10.1007/s10517-019-04572-3
doi: 10.1007/s10517-019-04572-3
pubmed: 31502127
Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain 136(Pt 8):2419–2431. https://doi.org/10.1093/brain/awt192
doi: 10.1093/brain/awt192
pubmed: 23884810
pmcid: 3722357
Korecka JA, van Kesteren RE, Blaas E, Spitzer SO, Kamstra JH, Smit AB, Swaab DF, Verhaagen J, Bossers K (2013) Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS ONE 8(5):e63862. https://doi.org/10.1371/journal.pone.0063862
doi: 10.1371/journal.pone.0063862
pubmed: 23724009
pmcid: 3665836
Lee J, Huang MS, Yang IC, Lai TC, Wang JL, Pang VF, Hsiao M, Kuo MY (2008) Essential roles of caspases and their upstream regulators in rotenone-induced apoptosis. Biochem Biophys Res Commun 371(1):33–38. https://doi.org/10.1016/j.bbrc.2008.03.149
doi: 10.1016/j.bbrc.2008.03.149
pubmed: 18402771
Lewitt PA (2008) Levodopa for the treatment of Parkinson’s disease. N Engl J Med 359(23):2468–2476. https://doi.org/10.1056/NEJMct0800326
doi: 10.1056/NEJMct0800326
pubmed: 19052127
Lin J, Sampath D, Nannini MA, Lee BB, Degtyarev M, Oeh J, Savage H, Guan Z, Hong R, Kassees R, Lee LB, Risom T, Gross S, Liederer BM, Koeppen H, Skelton NJ, Wallin JJ, Belvin M, Punnoose E, Lin K (2013) Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models. Clin Cancer Res 19(7):1760–1772. https://doi.org/10.1158/1078-0432.CCR-12-3072
doi: 10.1158/1078-0432.CCR-12-3072
pubmed: 23287563
Liu L, Geisert EE, Frankfurter A, Spano AJ, Jiang CX, Yue J, Dragatsis I, Goldowitz D (2007) A transgenic mouse class-III beta tubulin reporter using yellow fluorescent protein. Genesis 45(9):560–569. https://doi.org/10.1002/dvg.20325
doi: 10.1002/dvg.20325
pubmed: 17868115
pmcid: 2814058
Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, Gao G, Wu X, Wang X, Yang H (2018a) Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy 14(5):845–861. https://doi.org/10.1080/15548627.2017.1390636
doi: 10.1080/15548627.2017.1390636
pubmed: 29433359
pmcid: 6070010
Liu LX, Du D, Wang ZQ, Fang Y, Zheng T, Dong YC, Shi QL, Zhao M, Xiao F, Du J (2018b) Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models. Neural Regen Res 13(7):1276–1280. https://doi.org/10.4103/1673-5374.235076
doi: 10.4103/1673-5374.235076
pubmed: 30028338
pmcid: 6065241
Liu H, Wu H, Zhu N, Xu Z, Wang Y, Qu Y, Wang J (2020) Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease in mice. J Neurochem 152(3):397–415. https://doi.org/10.1111/jnc.14857
doi: 10.1111/jnc.14857
pubmed: 31442326
Looyenga BD, Resau J, MacKeigan JP (2013) Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway. PLoS ONE 8(6):e66548. https://doi.org/10.1371/journal.pone.0066548
doi: 10.1371/journal.pone.0066548
pubmed: 23818941
pmcid: 3688593
Lopes FM, da Motta LL, De Bastiani MA, Pfaffenseller B, Aguiar BW, de Souza LF, Zanatta G, Vargas DM, Schonhofen P, Londero GF, de Medeiros LM, Freire VN, Dafre AL, Castro MA, Parsons RB, Klamt F (2017) RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells. Neurotox Res 31(4):545–559. https://doi.org/10.1007/s12640-016-9699-0
doi: 10.1007/s12640-016-9699-0
pubmed: 28155214
Lúcio M, Nunes C, Gaspar D, Ferreira H, Lima JLFC, Reis S (2009) Antioxidant Activity of Vitamin E and Trolox: Understanding of the Factors that Govern Lipid Peroxidation Studies In Vitro. Food Biophys 4(4):312–320. https://doi.org/10.1007/s11483-009-9129-4
doi: 10.1007/s11483-009-9129-4
Maharjan S, Oku M, Tsuda M, Hoseki J, Sakai Y (2014) Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci Rep 4:5896. https://doi.org/10.1038/srep05896
doi: 10.1038/srep05896
pubmed: 25077633
pmcid: 4116626
Martinez MA, Rodriguez JL, Lopez-Torres B, Martinez M, Martinez-Larranaga MR, Maximiliano JE, Anadon A, Ares I (2020) Use of human neuroblastoma SH-SY5Y cells to evaluate glyphosate-induced effects on oxidative stress, neuronal development and cell death signaling pathways. Environ Int 135:105414. https://doi.org/10.1016/j.envint.2019.105414
doi: 10.1016/j.envint.2019.105414
pubmed: 31874349
Min KJ, Seo BR, Bae YC, Yoo YH, Kwon TK (2014) Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L). Cell Death Dis 5:e1063. https://doi.org/10.1038/cddis.2014.35
doi: 10.1038/cddis.2014.35
pubmed: 24556678
pmcid: 3944252
Nitulescu GM, Van De Venter M, Nitulescu G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Gradinaru D, Tsatsakis A, Tsoukalas D, Spandidos DA, Margina D (2018) The Akt pathway in oncology therapy and beyond (Review). Int J Oncol 53(6):2319–2331. https://doi.org/10.3892/ijo.2018.4597
doi: 10.3892/ijo.2018.4597
pubmed: 30334567
pmcid: 6203150
Nussbaum RL, Ellis CE (2003) Alzheimer’s disease and Parkinson’s disease. N Engl J Med 348(14):1356–1364. https://doi.org/10.1056/NEJM2003ra020003
doi: 10.1056/NEJM2003ra020003
pubmed: 12672864
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Stocchi F (2004) Levodopa in the treatment of Parkinson’s disease: current controversies. Mov Disord 19(9):997–1005. https://doi.org/10.1002/mds.20243
doi: 10.1002/mds.20243
pubmed: 15372588
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74(4):609–619. https://doi.org/10.1016/0092-8674(93)90509-o
doi: 10.1016/0092-8674(93)90509-o
pubmed: 8358790
Ozansoy M, Basak AN (2013) The central theme of Parkinson’s disease: alpha-synuclein. Mol Neurobiol 47(2):460–465. https://doi.org/10.1007/s12035-012-8369-3
doi: 10.1007/s12035-012-8369-3
pubmed: 23180276
Pakrashi S, Chakraborty J, Bandyopadhyay J (2020) Neuroprotective Role of Quercetin on Rotenone-Induced Toxicity in SH-SY5Y Cell Line Through Modulation of Apoptotic and Autophagic Pathways. Neurochem Res. https://doi.org/10.1007/s11064-020-03061-8
doi: 10.1007/s11064-020-03061-8
pubmed: 32488468
Pal R, Monroe TO, Palmieri M, Sardiello M, Rodney GG (2014) Rotenone induces neurotoxicity through Rac1-dependent activation of NADPH oxidase in SHSY-5Y cells. FEBS Lett 588(3):472–481. https://doi.org/10.1016/j.febslet.2013.12.011
doi: 10.1016/j.febslet.2013.12.011
pubmed: 24374334
Pezzini F, Bettinetti L, Di Leva F, Bianchi M, Zoratti E, Carrozzo R, Santorelli FM, Delledonne M, Lalowski M, Simonati A (2017) Transcriptomic Profiling Discloses Molecular and Cellular Events Related to Neuronal Differentiation in SH-SY5Y Neuroblastoma Cells. Cell Mol Neurobiol 37(4):665–682. https://doi.org/10.1007/s10571-016-0403-y
doi: 10.1007/s10571-016-0403-y
pubmed: 27422411
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/mds.26424
doi: 10.1002/mds.26424
pubmed: 26474316
Roskams AJ, Cai X, Ronnett GV (1998) Expression of neuron-specific beta-III tubulin during olfactory neurogenesis in the embryonic and adult rat. Neuroscience 83(1):191–200. https://doi.org/10.1016/s0306-4522(97)00344-8
doi: 10.1016/s0306-4522(97)00344-8
pubmed: 9466409
Rousseau E, Michel PP, Hirsch EC (2013) The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis. Mol Pharmacol 84(6):888–898. https://doi.org/10.1124/mol.113.087965
doi: 10.1124/mol.113.087965
pubmed: 24077968
Sahin C, Osterlund EC, Osterlund N, Costeira-Paulo J, Pedersen JN, Christiansen G, Nielsen J, Gronnemose AL, Amstrup SK, Tiwari MK, Rao RSP, Bjerrum MJ, Ilag LL, Davies MJ, Marklund EG, Pedersen JS, Landreh M, Moller IM, Jorgensen TJD, Otzen DE (2022) Structural Basis for Dityrosine-Mediated Inhibition of alpha-Synuclein Fibrillization. J Am Chem Soc 144(27):11949–11954. https://doi.org/10.1021/jacs.2c03607
doi: 10.1021/jacs.2c03607
pubmed: 35749730
pmcid: 9284551
Sakka N, Sawada H, Izumi Y, Kume T, Katsuki H, Kaneko S, Shimohama S, Akaike A (2003) Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone. NeuroReport 14(18):2425–2428. https://doi.org/10.1097/00001756-200312190-00027
doi: 10.1097/00001756-200312190-00027
pubmed: 14663204
Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson’s disease. J Neurosci 23(34):10756–10764 ( https://www.ncbi.nlm.nih.gov/pubmed/14645467 )
doi: 10.1523/JNEUROSCI.23-34-10756.2003
pubmed: 14645467
pmcid: 6740985
Simoes RF, Ferrao R, Silva MR, Pinho SLC, Ferreira L, Oliveira PJ, Cunha-Oliveira T (2021) Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research. Food Chem Toxicol 149:111967. https://doi.org/10.1016/j.fct.2021.111967
doi: 10.1016/j.fct.2021.111967
pubmed: 33417974
Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram AS, Karunakaran R, Rajasekaran R, Srikumar PS (2021) Alpha-Synuclein Aggregation in Parkinson’s Disease. Front Med (Lausanne) 8:736978. https://doi.org/10.3389/fmed.2021.736978
doi: 10.3389/fmed.2021.736978
pubmed: 34733860
Sun C, Wang D, Zheng W (2012) Hydrogen peroxide attenuates the prosurvival signaling of insulin-like growth factor-1 through two pathways. NeuroReport 23(13):768–773. https://doi.org/10.1097/WNR.0b013e328356f78a
doi: 10.1097/WNR.0b013e328356f78a
pubmed: 22797316
Sun H, He X, Liu C, Li L, Zhou R, Jin T, Yue S, Feng D, Gong J, Sun J, Ji J, Xiang L (2017) Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson’s Disease Cell and Animal Models. ACS Chem Neurosci 8(1):155–164. https://doi.org/10.1021/acschemneuro.6b00291
doi: 10.1021/acschemneuro.6b00291
pubmed: 27731637
Suzuki YA, Lonnerdal B (2002) Characterization of mammalian receptors for lactoferrin. Biochem Cell Biol 80(1):75–80. https://doi.org/10.1139/o01-228
doi: 10.1139/o01-228
pubmed: 11908646
Talpade DJ, Greene JG, Higgins DS Jr, Greenamyre JT (2000) In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem 75(6):2611–2621. https://doi.org/10.1046/j.1471-4159.2000.0752611.x
doi: 10.1046/j.1471-4159.2000.0752611.x
pubmed: 11080215
Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW (2011) Rotenone, paraquat, and Parkinson’s disease. Environ Health Perspect 119(6):866–872. https://doi.org/10.1289/ehp.1002839
doi: 10.1289/ehp.1002839
pubmed: 21269927
pmcid: 3114824
Wang J, Bi M, Liu H, Song N, Xie J (2015) The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability. Sci Rep 5:10729. https://doi.org/10.1038/srep10729
doi: 10.1038/srep10729
pubmed: 26035688
pmcid: 4451802
Weihe E, Depboylu C, Schutz B, Schafer MK, Eiden LE (2006) Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol Neurobiol 26(4–6):659–678. https://doi.org/10.1007/s10571-006-9053-9
doi: 10.1007/s10571-006-9053-9
pubmed: 16741673
pmcid: 4183211
Wu X, Liang Y, Jing X, Lin D, Chen Y, Zhou T, Peng S, Zheng D, Zeng Z, Lei M, Huang K, Tao E (2018) Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3beta/CREB Signaling Pathway. Neurochem Res 43(4):886–893. https://doi.org/10.1007/s11064-018-2494-y
doi: 10.1007/s11064-018-2494-y
pubmed: 29435803
Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson’s disease research: a systematic review. Mol Neurodegener 12(1):10. https://doi.org/10.1186/s13024-017-0149-0
doi: 10.1186/s13024-017-0149-0
pubmed: 28118852
pmcid: 5259880
Xu SF, Zhang YH, Wang S, Pang ZQ, Fan YG, Li JY, Wang ZY, Guo C (2019) Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice. Redox Biol 21:101090. https://doi.org/10.1016/j.redox.2018.101090
doi: 10.1016/j.redox.2018.101090
pubmed: 30593976
Yao Z, Li J, Bian L, Li Q, Wang X, Yang X, Wei X, Wan G, Wang Y, Shi J, Guo J (2022) Nootkatone alleviates rotenone-induced Parkinson’s disease symptoms through activation of the PI3K/Akt signaling pathway. Phytother Res. https://doi.org/10.1002/ptr.7552
doi: 10.1002/ptr.7552
pubmed: 36482025
Yong SJ, Veerakumarasivam A, Lim WL, Chew J (2023) Neuroprotective Effects of Lactoferrin in Alzheimer’s and Parkinson’s Diseases: A Narrative Review. ACS Chem Neurosci. https://doi.org/10.1021/acschemneuro.2c00679
doi: 10.1021/acschemneuro.2c00679
pubmed: 36995304
Zakharova ET, Kostevich VA, Sokolov AV, Vasilyev VB (2012) Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha. Biometals 25(6):1247–1259. https://doi.org/10.1007/s10534-012-9586-y
doi: 10.1007/s10534-012-9586-y
pubmed: 23001680
Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, Chechushkov AV, Voynova IV, Elizarova AY, Kolmakov NN, Bass MG, Semak IV, Budevich AI, Kozhin PM, Zenkov NK, Klimenko VM, Kirik OV, Korzhevskii DE, Menshchikova EB, Vasilyev VB (2018) Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals 31(3):425–443. https://doi.org/10.1007/s10534-018-0111-9
doi: 10.1007/s10534-018-0111-9
pubmed: 29748743
Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, Dong W (2016) ROS and ROS-Mediated Cellular Signaling. Oxid Med Cell Longev 2016:4350965. https://doi.org/10.1155/2016/4350965
doi: 10.1155/2016/4350965
pubmed: 26998193
pmcid: 4779832
Zhang Y, Guo H, Guo X, Ge D, Shi Y, Lu X, Lu J, Chen J, Ding F, & Zhang Q (2019). Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson's Disease Models. Int J Environ Res Public Health, 16(20). https://doi.org/10.3390/ijerph16203811
Zou J, Lei T, Guo P, Yu J, Xu Q, Luo Y, Ke R, Huang D (2019) Mechanisms shaping the role of ERK1/2 in cellular senescence (Review). Mol Med Rep 19(2):759–770. https://doi.org/10.3892/mmr.2018.9712
doi: 10.3892/mmr.2018.9712
pubmed: 30535440